Literature DB >> 23049074

Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.

Robert P Carson1, Cary Fu, Peggy Winzenburger, Kevin C Ess.   

Abstract

Tuberous sclerosis complex (TSC) is a multisystem genetic disorder with severe neurologic manifestations, including epilepsy, autism, anxiety and attention deficit hyperactivity disorder. TSC is caused by the loss of either the TSC1 or TSC2 genes that normally regulate the mammalian target of rapamycin (mTOR) kinase. mTOR exists within two distinct complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Loss of either TSC gene leads to increased mTORC1 but decreased mTORC2 signaling. As the contribution of decreased mTORC2 signaling to neural development and homeostasis has not been well studied, we generated a conditional knockout (CKO) of Rictor, a key component of mTORC2. mTORC2 signaling is impaired in the brain, whereas mTORC1 signaling is unchanged. Rictor CKO mice have small brains and bodies, normal lifespan and are fertile. Cortical layering is normal, but neurons are smaller than those in control brains. Seizures were not observed, although excessive slow activity was seen on electroencephalography. Rictor CKO mice are hyperactive and have reduced anxiety-like behavior. Finally, there is decreased white matter and increased levels of monoamine neurotransmitters in the cerebral cortex. Loss of mTORC2 signaling in the cortex independent of mTORC1 can disrupt normal brain development and function and may contribute to some of the neurologic manifestations seen in TSC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23049074      PMCID: PMC3522403          DOI: 10.1093/hmg/dds414

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  80 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

Review 2.  Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments.

Authors:  Margaret D Weiss; Jay Salpekar
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

3.  The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB.

Authors:  R M Biondi; A Kieloch; R A Currie; M Deak; D R Alessi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

4.  Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.

Authors:  Robert P Carson; Dominic L Van Nielen; Peggy A Winzenburger; Kevin C Ess
Journal:  Neurobiol Dis       Date:  2011-08-26       Impact factor: 5.996

5.  Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3).

Authors:  Teresa F Ackermann; Daniela S Kempe; Florian Lang; Undine E Lang
Journal:  Cell Physiol Biochem       Date:  2010-05-18

6.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Nicholas R Rensing; Bo Zhang; David H Gutmann; Michael J Gambello; Michael Wong
Journal:  Hum Mol Genet       Date:  2010-11-09       Impact factor: 6.150

7.  Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.

Authors:  Michael P Scheid; Paola A Marignani; James R Woodgett
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex.

Authors:  Sahayini Arulrajah; Gulhan Ertan; Lori Jordan; Aylin Tekes; Elizabeth Khaykin; Izlem Izbudak; Thierry A G M Huisman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

9.  Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.

Authors:  Martin Weber; Sonja Talmon; Ilka Schulze; Christine Boeddinghaus; Gerhard Gross; Hans Schoemaker; Karsten M Wicke
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

Review 10.  Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.

Authors:  Nicole A Neuman; Elizabeth Petri Henske
Journal:  EMBO Mol Med       Date:  2011-03-16       Impact factor: 12.137

View more
  38 in total

1.  Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice.

Authors:  Christopher J Yuskaitis; Leigh-Ana Rossitto; Sarika Gurnani; Elizabeth Bainbridge; Annapurna Poduri; Mustafa Sahin
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

2.  Myelin volume fraction imaging with MRI.

Authors:  Kathryn L West; Nathaniel D Kelm; Robert P Carson; Daniel F Gochberg; Kevin C Ess; Mark D Does
Journal:  Neuroimage       Date:  2016-12-23       Impact factor: 6.556

3.  A revised model for estimating g-ratio from MRI.

Authors:  Kathryn L West; Nathaniel D Kelm; Robert P Carson; Mark D Does
Journal:  Neuroimage       Date:  2015-08-20       Impact factor: 6.556

Review 4.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

5.  Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.

Authors:  Shan Wang; Katherine R Amato; Wenqiang Song; Victoria Youngblood; Keunwook Lee; Mark Boothby; Dana M Brantley-Sieders; Jin Chen
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

6.  Experimental studies of g-ratio MRI in ex vivo mouse brain.

Authors:  Kathryn L West; Nathaniel D Kelm; Robert P Carson; Daniel C Alexander; Daniel F Gochberg; Mark D Does
Journal:  Neuroimage       Date:  2017-12-05       Impact factor: 6.556

7.  Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.

Authors:  Jordi Creus-Muncunill; Laura Rué; Rafael Alcalá-Vida; Raquel Badillos-Rodríguez; Joan Romaní-Aumedes; Sonia Marco; Jordi Alberch; Isabel Perez-Otaño; Cristina Malagelada; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

8.  Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1.

Authors:  Lindsay K Klofas; Brittany P Short; Chengwen Zhou; Robert P Carson
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

Review 9.  Advancing the discovery of medications for autism spectrum disorder using new technologies to reveal social brain circuitry in rodents.

Authors:  Martien J Kas; Meera E Modi; Michael D Saxe; Daniel G Smith
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

10.  Rictor is an independent prognostic factor for endometrial carcinoma.

Authors:  Shan-Yun Wen; Chang-Hua Li; Yan-Li Zhang; Yu-Hai Bian; Li Ma; Qiu-Lin Ge; Yin-Cheng Teng; Zhi-Gang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.